Cherk Martin H, Zolio Luigi, Khan Sadid, Brady Sharmayne
Department of Nuclear Medicine & PET Alfred Hospital, Melbourne, Australia.
Monash University, Melbourne, Australia.
EJNMMI Rep. 2025 Apr 8;9(1):12. doi: 10.1186/s41824-025-00247-7.
There have been several case reports of COVID-19 "BNT162b2" (Pfizer-BioNTech) and "mRNA-1273" (Moderna) vaccination associated small and medium vessel vasculitis described in the literature however none have had F-FDG Positron Emission Tomography scans (PET/CT) performed for diagnosis. We report the case of a 57-year-old Caucasian male patient from Australia where F-FDG PET/CT scanning facilitated early detection of a medium-vessel vasculitis following Moderna (mRNA-1273) COVID-19 vaccination. The diagnosis would otherwise have been difficult and allowed exclusion of alternative diagnoses and sparing of more invasive investigations such as muscle biopsy. Our case highlights the development of a medium vessel vasculitis following mRNA based COVID-19 vaccination and demonstrates the utility of F-FDG PET/CT as an excellent non-invasive test for the detection of this serious rare and often difficult to diagnose condition.
文献中已有多篇关于新冠病毒“BNT162b2”(辉瑞 - 生物科技公司)和“mRNA - 1273”(莫德纳公司)疫苗接种相关的中小血管血管炎的病例报告,但均未进行F - FDG正电子发射断层扫描(PET/CT)以辅助诊断。我们报告了一名来自澳大利亚的57岁白种男性患者的病例,该患者在接种莫德纳(mRNA - 1273)新冠疫苗后,F - FDG PET/CT扫描有助于早期发现中型血管血管炎。否则,诊断将很困难,且该检查可排除其他诊断,并避免进行如肌肉活检等更具侵入性的检查。我们的病例突出了基于mRNA的新冠疫苗接种后中型血管血管炎的发生,并证明了F - FDG PET/CT作为检测这种严重、罕见且通常难以诊断疾病的优秀非侵入性检查的实用性。